Muneer A. Satter, Director, 10% Owner at Aerpio Pharmaceuticals, Inc. (ARPO), bought 5,000 shares at $5.00 ($24K) on 2018-03-23, disclosed to the SEC on 2018-03-23.
Open-market purchase of $24k ARPO by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.85 | 4,000 | $19K | 79.5% |
| 2 | $5.00 | 1,000 | $5K | 20.5% |
| Total | $4.88 avg | 5,000 | $24K | 100% |
| Filing → |
| ANNX | BUY | 2025-11-19 | $5.1M | — | Filing → |
| ANNX | BUY | 2023-12-28 | $1.0M | — | Filing → |
| ANNX | BUY | 2023-02-14 | $36.0M | — | Filing → |